Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-07-11T17:13:29Z No. of bitstreams: 1 RodrigoPorpinoMafra_DISSERT.pdf: 2938922 bytes, checksum: c44070e8d06f2305cff5199e620a1c1c (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-07-15T20:45:06Z (GMT) No. of bitstreams: 1 RodrigoPorpinoMafra_DISSERT.pdf: 2938922 bytes, checksum: c44070e8d06f2305cff5199e620a1c1c (MD5) / Made available in DSpace on 2016-07-15T20:45:06Z (GMT). No. of bitstreams: 1 RodrigoPorpinoMafra_DISSERT.pdf: 2938922 bytes, checksum: c44070e8d06f2305cff5199e620a1c1c (MD5) Previous issue date: 2016-02-16 / O carcinoma epiderm?ide de l?ngua oral (CELO) apresenta um comportamento biol?gico agressivo, com elevada propens?o ao desenvolvimento de met?stases nodais. Nesse contexto, a linfangiog?nese ? considerada um fen?meno importante para a dissemina??o das c?lulas tumorais e pode sofrer influ?ncia de est?mulos do microambiente. Os mast?citos t?m sido relacionados ? progress?o de neoplasias malignas, no entanto o seu papel na forma??o de vasos linf?ticos ainda n?o est? bem estabelecido. O prop?sito desta pesquisa foi avaliar poss?veis correla??es entre a densidade linf?tica, a contagem de mast?citos e o perfil clinicopatol?gico em casos de CELO, incluindo o estadiamento cl?nico TNM, a grada??o histol?gica de malignidade (Bryne, 1998) e a presen?a/aus?ncia de met?stases nodais. A amostra foi constitu?da por 50 casos de CELO, dos quais 26 apresentavam met?stase nodal, e os 24 restantes eram isentos de met?stases. A densidade linf?tica foi estabelecida como a m?dia de vasos linf?ticos imunomarcados pelo anticorpo anti-podoplanina (D2-40), identificados em cinco campos microsc?picos (200x). Para a an?lise dos mast?citos, foram quantificadas as c?lulas imunorreativas ao anticorpo anti-triptase, em cinco campos (400x). Destaca-se que ambas as imunomarca??es foram analisadas no centro tumoral e no front de invas?o. A densidade linf?tica intratumoral (DLI) foi superior nos casos em est?gios cl?nicos avan?ados (III-IV), quando comparados ?queles em est?gios iniciais (I-II), assim como nos casos metast?ticos em rela??o aos n?o-metast?ticos (p<0,05). N?o houve diferen?as estatisticamente significativas entre os casos de baixo grau e alto grau de malignidade no tocante ? DLI (p>0,05). De outro modo, a densidade linf?tica peritumoral (DLP) e as contagens de mast?citos n?o demonstraram rela??es significativas com nenhum dos par?metros clinicopatol?gicos avaliados (p>0,05). Tamb?m n?o foram encontradas correla??es significativas entre as densidades linf?ticas e as contagens de mast?citos, seja na regi?o intratumoral (r = -0,004; p=0,977) ou na peritumoral (r = -0,154; p=0,285). Os resultados do presente estudo sugerem que os vasos linf?ticos intratumorais contribuem na progress?o do CELO. Por sua vez, a DLP pode n?o ser suficiente para justificar diferen?as no comportamento biol?gico do CELO, o que sustenta a hip?tese de envolvimento de outros mecanismos na dissemina??o metast?tica das c?lulas malignas, que complementariam os efeitos da linfangiog?nese. Os mast?citos, ainda que realizem diversas fun??es pr?- e antitumorais, parecem n?o influenciar diretamente o potencial de agressividade do CELO. Adicionalmente, ? poss?vel que a quantidade destas c?lulas n?o seja um fator determinante para a forma??o de vasos linf?ticos. / Oral tongue squamous cell carcinoma (OTSCC) has an aggressive biological behavior, with a high propensity for the development of lymph node metastases. In this context, lymphangiogenesis is considered an important phenomenon for the spread of tumor cells and may be influenced by microenvironmental stimuli. Mast cells have been implicated in tumor progression, although their influence in the formation of lymphatic vessels is not well established. The aim of this study was to analyze, in a case series of OTSCC (n=50), possible correlations between lymphatic vessel density (LVD), mast cell count and clinicopathological features, including tumor-node-metastasis (TNM) stage, histological grade of malignancy (Bryne, 1998), and nodal metastasis. LVD was established as the mean number of lymphatic vessels immunostained by anti-podoplanin (D2-40) antibody, identified in five microscopic fields (200x). For the analysis of mast cells, tryptase-immunoreactive cells were quantified in five fields (400x). Both immunostainings were analyzed in the tumor center and invasion front. Intratumoral lymphatic density (ILD) was higher in cases in advanced clinical stages (III-IV), compared to those in initial stages (I-II), as well as in metastatic cases in respect of non-metastatic (p<0,05). There were no statistically significant differences between low-grade and high-grade malignancy cases with respect to ILD (p>0,05). Peritumoral lymphatic density (PLD) and mast cell counts showed no significant relations with any of the clinicopathological parameters evaluated (p>0,05). Also there were no significant correlations between LVD and mast cell counts, whether in intratumoral (r = -0,004; p=0,977) or peritumoral region (r = -0,154; p=0,285). The results of the present study suggest that intratumoral lymphatic vessels may contribute in part to the progression of OTSCC, although PLD may be insufficient to justify differences in biological behavior. This supports the hypothesis of involvement of other mechanisms in metastatic spread of malignant cells, which could complement the effects of lymphangiogenesis. Although mast cells perform several pro- and antitumoral functions, they do not appear to directly influence aggressiveness of OTSCC. In addition, the quantity of these cells may not be essential for lymphatic vessel formation.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-07-11T17:13:29Z No. of bitstreams: 1 ThalitaSantanaConceicao_DISSERT.pdf: 2109547 bytes, checksum: 6d0e119c0da68d509313a90708cf7879 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-07-15T21:04:56Z (GMT) No. of bitstreams: 1 ThalitaSantanaConceicao_DISSERT.pdf: 2109547 bytes, checksum: 6d0e119c0da68d509313a90708cf7879 (MD5) / Made available in DSpace on 2016-07-15T21:04:56Z (GMT). No. of bitstreams: 1 ThalitaSantanaConceicao_DISSERT.pdf: 2109547 bytes, checksum: 6d0e119c0da68d509313a90708cf7879 (MD5) Previous issue date: 2016-02-19 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico - CNPq / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES) / Os sistemas de reparo do DNA desempenham um papel cr?tico na prote??o do genoma humano contra danos causados por agentes cancer?genos presentes no ambiente. Muta??es em genes de reparo de DNA podem ser respons?veis pelo desenvolvimento de tumores e de resist?ncia das c?lulas malignas a agentes quimioterap?uticos. A principal via de reparo de danos oxidativos do DNA ? a via de reparo por excis?o de bases. O objetivo deste estudo foi investigar a imunoexpress?o da APE-1 e XRCC-1, que s?o prote?nas envolvidas no reparo do DNA por excis?o de bases, e sua associa??o com par?metros cl?nicos e histopatol?gicos em carcinoma epidermoide de l?ngua oral (CELO), a fim de investigar um poss?vel valor progn?stico para essas prote?nas. A express?o de APE-1 e XRCC-1 foi avaliada por meio de imuno-histoqu?mica em 50 casos de CELO. Os dados cl?nicos foram coletados no prontu?rio m?dico de cada paciente e a grada??o histopatol?gica foi efetuada para cada caso. A an?lise estat?stica com os testes de Qui-quadrado e Exato de Fisher foi realizada para determinar a associa??o entre as express?es das prote?nas e caracter?sticas cl?nico-patol?gicas; adotou-se um valor de signific?ncia de p<0,05. APE-1 foi altamente expressa no n?cleo e no citoplasma em 56% dos casos. XRCC-1 mostrou alta express?o apenas no n?cleo em 60% dos casos. A alta express?o de XRCC-1 foi significativamente associada aos est?dios cl?nicos I e II (p = 0,02). Ambas as prote?nas n?o foram associadas a outros par?metros cl?nicos ou grada??o histopatol?gica. Por fim, nossos resultados demonstraram que as prote?nas de reparo do DNA por excis?o de bases APE-1 e XRCC-1 est?o positivamente expressas em CELO, no entanto, n?o est?o relacionadas com par?metros cl?nicos e histol?gicos, exceto a associa??o de XRCC-1 com melhor estadiamento cl?nico. Os resultados deste experimento indicam que a express?o imuno-histoqu?mica dessas prote?nas n?o possui valor progn?stico para esta neoplasia. / DNA repair systems play a critical role in protecting the human genome from damage caused by carcinogens present in the environment. Mutations in DNA repair genes may be responsible for tumor development and resistance of malignant cells to chemotherapeutic agents. The major pathway for oxidative DNA damage repair is the base excision repair pathway. The objective of this study was to investigate the immunoexpression of APE-1 and XRCC-1, which are proteins involved in DNA base excision repair and its association with clinical and histopathological parameters in oral tongue squamous cell carcinoma (OTSCC), in order to investigate a possible prognostic value for those proteins. The expression of APE-1 and XRCC-1 was evaluated semi-quantitatively by immunohistochemistry in 50 OTSCC cases. Clinical data was collected from patients? medical charts and histopathological grading was performed for each case. Statistical analysis (Chi-square and Fisher?s exact tests; significance of 5%) was performed to determine the association between protein expressions and clinico-pathological characteristics. APE-1 was highly expressed in nucleus and cytoplasm in 56% of cases. XRCC-1 showed overexpression only in nucleus in 60% of cases. High expression of XRCC-1 was significantly associated to clinical stages I and II (P=0.02). Both proteins were not associated to other clinical parameters or histopathological grading. Our findings demonstrate that DNA base excision repair proteins APE-1 and XRCC-1 are upregulated in OTSCC, however, they are not related to clinical and histologic parameters, except for XRCC-1 association to better clinical staging. Our results indicate that the immunohistochemical expression of these proteins has no association with prognostic parameters in this tumor.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-07-21T17:20:00Z No. of bitstreams: 1 MelkaCoelhoSa_TESE.pdf: 3257998 bytes, checksum: 6feeeb452aad7be3dee1941b26d85af8 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-07-22T11:49:09Z (GMT) No. of bitstreams: 1 MelkaCoelhoSa_TESE.pdf: 3257998 bytes, checksum: 6feeeb452aad7be3dee1941b26d85af8 (MD5) / Made available in DSpace on 2016-07-22T11:49:09Z (GMT). No. of bitstreams: 1 MelkaCoelhoSa_TESE.pdf: 3257998 bytes, checksum: 6feeeb452aad7be3dee1941b26d85af8 (MD5) Previous issue date: 2016-02-19 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico - CNPq / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES) / Os genes de reparo do DNA s?o essenciais para manuten??o da integridade do genoma, evitando graves doen?as como o c?ncer. O papel de v?rias prote?nas codificadas por esses genes vem sendo associado tanto ao risco do desenvolvimento, como na evolu??o de variados c?nceres humanos, dentre eles, o carcinoma epidermoide oral. O objetivo deste trabalho foi analisar a imunoexpress?o das prote?nas de reparo do DNA, XRCC1, THIIF e XPF em carcinoma epidermoide de l?ngua oral e investigar associa??o com par?metros cl?nicos, histopatol?gicos e de desfecho. Tamanho do tumor, comprometimento linfonodal, est?gio do tumor, profundidade de invas?o >4mm e o sistema de grada??o de Almangush, mostraram-se como fatores progn?sticos. Evidenciou-se de uma maneira geral, alta express?o imuno-histoqu?mica das prote?nas de reparo nas c?lulas parenquimatosas; no entanto, apenas verificou-se associa??o significativa da elevada express?o de XRCC1 com melhor estadiamento cl?nico. Os resultados deste experimento sugerem que as prote?nas XRCC1, TFIIH e XPF participam do processo de tumorig?nese, entretanto a imunoexpress?o das mesmas n?o pode ser utilizada como indicador progn?stico para o carcinoma epidermoide de l?ngua oral. / DNA repair systems, genes and proteins are essential for genome integrity maintenance, avoiding serious diseases such as cancer. Deregulation in the expression of those proteins has been associated with both the risk of development and evolution of various human cancers, including oral squamous cell carcinoma. The purpose of this study was to analyze the immunoreactivity of the DNA repair proteins XRCC1, THIIF and XPF in oral tongue squamous cell carcinoma (OTSCC) and to investigate its association with clinical and histopathological parameters, outcome and 5-year survival rate. Seventy-four cases of OTSCC were analyzed semi-quantitatively through immunohistochemistry. We observed that DNA repair proteins were highly expressed in parenchymal cells; however, we only observed a significant association between XRCC1 high expression and better clinical staging (p=0,02). Cox regression showed that tumor size (p<0,01), lymph node involvement (p=0,04), tumor stage (p=0,02) and depth of invasion> 4mm (p=0,05) were prognostic factors. The results of this experiment suggest that XRCC1, TFIIH and XPF participate in the tumorigenic process, however, their immunoexpression may not be used as an independent prognostic indicator for OTSCC.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-08-25T20:42:57Z No. of bitstreams: 1 EdilmarDeMouraSantos_TESE.pdf: 2404882 bytes, checksum: 5eff55db010b690ecc915ee6c24050f0 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-08-26T19:45:12Z (GMT) No. of bitstreams: 1 EdilmarDeMouraSantos_TESE.pdf: 2404882 bytes, checksum: 5eff55db010b690ecc915ee6c24050f0 (MD5) / Made available in DSpace on 2016-08-26T19:45:12Z (GMT). No. of bitstreams: 1 EdilmarDeMouraSantos_TESE.pdf: 2404882 bytes, checksum: 5eff55db010b690ecc915ee6c24050f0 (MD5) Previous issue date: 2016-02-24 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico (CNPq) / Falhas nos genes respons?veis por reparos no DNA podem influenciar no surgimento de c?ncer ou afetar a resposta aos tratamentos. Estudos t?m demonstrado que a varia??o na capacidade de reparo do DNA pode ser resultado de polimorfismos funcionais nestes genes, e alguns destes experimentos sugerem que a presen?a de polimorfismos de nucleot?deos simples (SNPs), em genes de reparo, est? relacionada ao desenvolvimento e resposta ao tratamento de v?rios c?nceres, incluindo o Carcinoma Epidermoide Oral (CEO) e o Carcinoma Epidermoide de Orofaringe (CEOR). Nesta pesquisa avaliou-se a frequ?ncia de tr?s SNPs em dois genes de reparo do DNA RAD51 172G>T (c.-61 G>T, rs1801321), RAD51 135G>C (c.-98 G>C, rs1801320) e XRCC3 T241M (c. 722 C>T, rs861539) em indiv?duos saud?veis (n=130) e indiv?duos com CEO e CEOR (n=126) e investigou-se poss?veis rela??es de tais achados com os desfechos cl?nicos: resposta tumoral ao tratamento com radioterapia e quimioterapia, recidiva, e sobrevida global. Constatou-se frequ?ncia al?lica e genot?pica em equil?brio. A presen?a dos SNPs analisados n?o revelou ser um fator de risco para o desenvolvimento de CEO ou CEOR; contudo, quando associado ao h?bito de fumar ou beber, aumentou o risco de desenvolver o c?ncer de tr?s a cento e cinquenta vezes (p<000,1). A resposta tumoral ao tratamento de radioterapia e quimioterapia foi semelhante nos pacientes com ou sem SNPs. Nenhum polimorfismo demonstrou signific?ncia estat?stica em rela??o ? sobrevida livre de recidiva ou sobrevida global. Os gen?tipos AA e AC do SNP rs861539 no gene XRCC3, os gen?tipos CC e CG do SNP rs1801320 e GG e GT do SNP 1801321 no gene RAD51, aumentam o risco do desenvolvimento de carcinoma epidermoide oral e de orofaringe, quando associados ao h?bito de beber ou fumar. Os polimorfismos estudados nos genes XRCC3 e RAD51 n?o est?o associados ? resposta ? radioterapia, sobrevida livre de recidiva ou sobrevida global. / Faults in the genes responsible for repairs to the DNA can influence the onset of cancer or affect the response to treatment. This research evaluated the frequency of three single nucleotide polymorphisms (SNPs) in two repair genes DNA RAD51 172g> T (rs1801321), RAD51 135G> C (rs1801320) and XRCC3 T241M (rs861539) in individuals without cancer (n = 130) and patients with oral squamous cell carcinoma (OSC) and carcinoma oropharyngeal squamous (ORSC) (n = 126) and investigated possible relationships of these findings with clinical and pathological data and clinical outcomes: tumor response to radiotherapy and chemotherapy, disease-free survival, and overall survival. It was found that the allele and genotype frequencies were in equilibrium Hard-Weinberg equilibrium. The presence of at least one polymorphic allele in XRCC3 (rs861539) gene is associated with histological grade (WHO) higher (p = 0.007). We observed a higher recurrence rate trend (p = 0.08) and more advanced stage (p = 0.08) in the group that had at least one polymorphic allele of RAD51 gene (rs1801321). The presence of the analyzed SNPs not proved to be a risk factor for the development of CEO or CEOR; however, when combined with smoking or drinking, increased the risk of developing cancer from three to one hundred and fifty times. The tumor response to radiotherapy and chemotherapy was similar in patients with and without SNPs. No polymorphism showed statistical significance in relation to recurrence-free survival or overall survival. We conclude that the presence of at least one polymorphic allele of the SNPs rs861539 in XRCC3 gene, rs1801320 and rs1801321 in the RAD51 gene increase the risk of development of OSC and ORSC, when associated with the habit of drinking or smoking. Polymorphisms studied in XRCC3 and RAD51 genes are not associated with response to radiation therapy, relapse-free survival or overall survival.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-08-25T20:42:57Z No. of bitstreams: 1 JamileMarinhoBezerraDeOliveiraMoura_TESE.pdf: 18433655 bytes, checksum: e3b33cd1bc7a5e8e3f1a6cdd83ebdcbd (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-08-26T20:02:15Z (GMT) No. of bitstreams: 1 JamileMarinhoBezerraDeOliveiraMoura_TESE.pdf: 18433655 bytes, checksum: e3b33cd1bc7a5e8e3f1a6cdd83ebdcbd (MD5) / Made available in DSpace on 2016-08-26T20:02:15Z (GMT). No. of bitstreams: 1 JamileMarinhoBezerraDeOliveiraMoura_TESE.pdf: 18433655 bytes, checksum: e3b33cd1bc7a5e8e3f1a6cdd83ebdcbd (MD5) Previous issue date: 2016-02-25 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico (CNPq) / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES) / As neoplasias de gl?ndulas salivares exibem uma ampla variedade de comportamento biol?gico e grande diversidade morfol?gica, e esta heterogeneidade inerente a este grupo de tumores suscita o interesse em pesquisar estas les?es. As c?lulas-tronco s?o a principal fonte para a gera??o e manuten??o da diversidade celular e homeostase do tecido, dist?rbios na regula??o destas c?lulas podem levar ? produ??o de c?lulas-tronco alteradas, denominadas de c?lulas-tronco tumorais, que possuem potencial proliferativo e capazes de originar e/ou manter o tumor. Pesquisas acerca das c?lulas-tronco tumorais e das prote?nas a elas associadas em algumas neoplasias orais t?m sido desenvolvidas, no entanto, o papel destas em neoplasias de gl?ndulas salivares n?o est? ainda bem estabelecido. Desta forma, o objetivo deste estudo foi identificar c?lulas do par?nquima tumoral que expressam marcadores de c?lulas-tronco tumorais, atrav?s da avalia??o da imunoexpress?o do OCT4 e CD44, em uma s?rie de casos de neoplasias de gl?ndulas salivares. A amostra foi constitu?da por 20 adenomas pleom?rficos, 20 carcinomas mucoepiderm?ides e 20 carcinomas aden?ides c?sticos localizados nas gl?ndulas salivares menores e maiores. Todos os casos estudados exibiram express?o positiva para OCT4 e CD44, sendo observado que para ambos marcadores, as neoplasias localizadas nas gl?ndulas salivares maiores exibiram maior imunomarca??o quando comparada com as les?es das gl?ndulas salivares menores apresentando diferen?a estatisticamente significativa (p=<0,001). Na amostra total e no grupo das gl?ndulas salivares menores, as neoplasias malignas exibiram maior imunorreatividade para OCT4 do que o adenoma pleom?rfico. No entanto, n?o foi encontrada diferen?as estatisticamente significativas de imunoexpress?es entre as les?es e entre suas classifica??es/grada??es histomorfol?gicas. Analisando a correla??o entre as imunoexpress?es de OCT4 e CD44 foi observada uma correla??o positiva moderada (r=0,444) com signific?ncia estat?stica entre os mesmos. A elevada express?o de OCT4 e CD44 pode indicar que estas prote?nas desempenham papel importante na identifica??o de c?lulas-tronco tumorais, permitindo uma previs?o do comportamento biol?gico das neoplasias de gl?ndula salivar, apresentando n?veis menores em tumores benignos e maiores nos tumores malignos. / Salivary gland neoplasms exhibit a wide variety of biological behavior and a high morphological diversity raises the interest in researching these lesions. The stem cells are the main source for the generation and maintenance of cell diversity, disorders in the regulation of these cells can lead to the production of altered stem cells, termed cancer stem cells capable of generate the tumor. Researches on cancer stem cells and associated proteins have been developed in some oral cancers; however, their role in salivary gland neoplasms is not well established. Thus, the aim of this study was to identify the tumor parenchyma cells exhibiting stem cell characteristics, by evaluating the immunoreactivity of OCT4 and CD44, in a number of cases of salivary gland neoplasms. The sample consisted of 20 pleomorphic adenomas, 20 mucoepidermoid carcinomas and 20 adenoid cystic carcinoma located in minor and major salivary glands. The expression of OCT4 and CD44 was evaluated by the percentage of positive cells (PP) and the intensity of expression (IE), it is realized the sum of the scores, resulting in the total score immunostaining (PIT) ranging 0-7. All studied cases showed positive expression of OCT4 and CD44 and higher values than the control groups. It was observed that for OCT4 luminal cells and non-luminal were immunostained in the case of pleomorphic adenomas and adenoid cystic carcinoma. Already the immunoreactivity of CD44 was particularly evident in the non-luminal cells of these lesions. In mucoepidermoid carcinomas for both markers, there was immunoreactivity in squamous and intermediate cells and absence of staining mucous cells. For both markers, a statistically significant higher immunostaining was verified in neoplasms located in the major salivary glands compared with lesions in the minor salivary (p<0.001). At the total sample and in the group of minor salivary glands, malignant neoplasms exhibited higher immunoreactivity for OCT4 than pleomorphic adenoma. However, there was no statistically significant difference between the lesions and between their classifications histomorphologic. Analyzing the correlation between OCT4 and CD44 immunoexpressions, a statistically significant moderate positive correlation (r = 0.444) was observed. The high expression of OCT4 and CD44 may indicate that these proteins play an important role in identifying cancer stem cells, allowing a prediction of biological behavior of salivary gland neoplasms.

Submitted by Automação e Estatística (sst@bczm.ufrn.br) on 2018-06-05T21:48:08Z No. of bitstreams: 1 LarissaSantosAmaralRolim_DISSERT.pdf: 2305138 bytes, checksum: 14b3b617e544762c66ebb1f48bfcb9de (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2018-06-11T19:21:02Z (GMT) No. of bitstreams: 1 LarissaSantosAmaralRolim_DISSERT.pdf: 2305138 bytes, checksum: 14b3b617e544762c66ebb1f48bfcb9de (MD5) / Made available in DSpace on 2018-06-11T19:21:02Z (GMT). No. of bitstreams: 1 LarissaSantosAmaralRolim_DISSERT.pdf: 2305138 bytes, checksum: 14b3b617e544762c66ebb1f48bfcb9de (MD5) Previous issue date: 2018-02-23 / Introdução: O Carcinoma de Células Escamosas Oral (CCEO) é um grande problema de saúde pública em todo o mundo. Acredita-se que o mecanismo responsável pela progressão tumoral seja baseado na invasão coletiva ou de células individuais, chamado de Transição Epitelial-Mesenquimal (TEM), onde ocorre uma diminuição da expressão de biomarcadores epiteliais e aumento da expressão de biomarcadores mesenquimais, como Twist. A Podoplanina (PDPN), uma glicoproteína transmembranar, está envolvida na motilidade das células neoplásicas que estão passando pela TEM para orientar o complexo celular durante a invasão. Objetivo: Realizar uma análise comparativa entre a imunoexpressão da PDPN e do Twist em 40 casos de CCEs de lábio inferior (CCELI) e 36 casos de língua oral (CCELO), para analisar possíveis associações com parâmetros clínicos-patológicos (tamanho do tumor primário, metástase linfonodal regional e à distância, estadiamento clínico, grau histológico de malignidade e padrão histológico de invasão). Métodos: Para avaliação do grau histopatológico de malignidade, utilizou-se o sistema proposto por Brandwein-Gensler et al (2005). Para os dois marcadores, quatro tipos de análises imuno-histoquímica foram realizados: análise do front de invasão, das áreas compressivas do tumor, das grandes ilhas tumorais (>15 células neoplásicas) e dos ninhos/células dissociadas (<15 células neoplásicas). Para a análise das relações entre os parâmetros clínicos e histopatológicos e as imunoexpressões de PDPN e Twist, foi utilizado o teste não paramétrico de Mann-Whitney. Para verificar possíveis correlações entre as imunoexpressões de PDPN e Twist, foi realizado o teste de correlação de Spearman (r). Para todos os testes estatísticos, foi estabelecido um nível de significância de 5% (p < 0,05). Resultados: Não foram encontradas diferenças estatisticamente significativas na imunoexpressão de PDPN e Twist em relação ao tamanho do tumor, metástase e estadiamento clínico de CCELI (p > 0,05). Porém foram encontradas diferenças estatisticamente significativas na imunoexpressão citoplasmástica de PDPN em relação aos padrões de invasão tipo 4 e 5 (p = 0,032) de Brandwein-Gensler et al. (2005). Também não foram observadas diferenças estatisticamente significativas na imunoexpressão de PDPN e Twist em relação ao tamanho do tumor, metástase e estadiamento clínico de CCELO (p > 0,05). Observou-se diferenças estatisticamente significativas entre a expressão citoplasmática (p = 0,006), membranar (p = 0,030) e geral (p = 0,025) de PDPN nos CCELO com os padrões de invasão tipo 4 e 5 de Brandwein-Gensler et al. (2005). Além disso, foram observadas correlações negativas estatisticamente significativas entre a expressão membranar da PDPN e as expressões geral (r = -0,356; p = 0,024) e citoplasmática do Twist (r = -0,336; p = 0,034) nos CCELI. Conclusões: A expressão da PDPN está inversamente relacionada com o Twist em CCELI, além de demonstrar que ambas proteínas estão associadas com um pior padrão de invasão nos CCELI e CCELO. Também, levantou-se a hipótese de que a relação da PDPN com o Twist em CCELI e CCELO possa estar mais envolvida com uma transição parcial do fenótipo epitelial para o mesenquimal do que uma transição completa coordenada pela PDPN. / Introduction: Oral Squamous Cell Carcinoma (OSCC) is a major public health problem worldwide. It is believed that the mechanism responsible for tumor progression is based on collective invasion of cell groups or individual cells, called Epithelial-Mesenchymal Transition (EMT), where there is a decrease in the expression of epithelial biomarkers and increased expression of mesenchymal biomarkers as Twist. Podoplanin (PDPN), a transmembrane glycoprotein, is assumed to be involved in the motility of neoplastic cells that are undergoing through EMT to guide the cell complex during an invasion. Objective: To perform a comparative analysis of the immunoexpression of PDPN and Twist among 40 cases of lower lip CCEs and 36 cases of oral tongue, (primary tumor size, regional and distal lymph node metastasis, clinical staging, histological grade of malignancy and histological pattern of invasion). Methods: To evaluate the histopathological grade of malignancy, the system proposed by Brandwein-Gensler et al. (2005) was used. For the two markers, four types of immunohistochemical analysis were performed: analysis of the invasion front, tumor compressive areas, large tumor islands (> 15 neoplastic cells) and nests/dissociated cells (<15 neoplastic cells). The non-parametric Mann-Whitney test was used for the analysis of the relationships between the clinical and histopathological parameters and the PDPN and Twist immunoexpressions. To verify possible correlations between the PDPN and Twist immunoexpressions, the Spearman (r) correlation test was performed. For all statistical tests, a significance level of 5% (p <0.05) was established. Results: No statistically significant differences were found between PDPN and Twist immunoexpression and tumor size, metastasis, and clinical staging on lower lip SCC (p > 0.05). However, statistically significant differences were found between the cytoplasmic immunoexpression of PDPN and the invasion patterns type 4 and 5 (p = 0.032) of Brandwein-Gensler et al. (2005). Also, no statistically significant differences were found between PDPN and Twist immunoexpression and tumor size, metastasis and clinical staging on oral tongue SCC (p > 0.05). Statistically significant differences were observed between the cytoplasmic (p = 0.006), membrane (p = 0.030) and general (p = 0.025) PDPN expression in oral tongue SCC with the invasion patterns type 4 and 5 of Brandwein-Gensler et al. (2005). In addition, the Spearman correlation test demonstrated statistically significant negative correlations between PDPN membrane expression and Twist general expression (r = -0.356, p = 0.024) and Twist cytoplasmic expression (r = -0.336; p = 0.034) in the lower lip SCCs. Conclusions: PDPN expression is inversely related to Twist in lower lip SCC, it was demonstrated that both proteins are associatved with a worse invasion pattern in SCC. It has also been hypothesized that the relationship of PDPN with Twist in OSCC may be more involved with a partial transition from the epithelial to the mesenchymal phenotype than a complete transition coordinated by PDPN.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-07-11T17:13:30Z No. of bitstreams: 1 EduardoAlonsoCruzMonroy_DISSERT.pdf: 2026837 bytes, checksum: 07d08221eedeeea6100a427aaf6ca1d9 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-07-14T17:30:27Z (GMT) No. of bitstreams: 1 EduardoAlonsoCruzMonroy_DISSERT.pdf: 2026837 bytes, checksum: 07d08221eedeeea6100a427aaf6ca1d9 (MD5) / Made available in DSpace on 2016-07-14T17:30:27Z (GMT). No. of bitstreams: 1 EduardoAlonsoCruzMonroy_DISSERT.pdf: 2026837 bytes, checksum: 07d08221eedeeea6100a427aaf6ca1d9 (MD5) Previous issue date: 2016-02-26 / Les?es odontog?nicas epiteliais benignas s?o entidades de grande import?ncia cl?nica que se desenvolvem nos ossos maxilares a partir dos tecidos que formam os dentes. Tem sido demonstrado que em tumores benignos e malignos, est?o presentes um grande n?mero de c?lulas tronco tumorais, as quais tem grandes implica??es no desenvolvimento dos tumores. Oct-4 e CD44 t?m sido demostrados como importantes marcadores para c?lulas-tronco tumorais. O objetivo deste estudo foi identificar c?lulas epiteliais que expressam marcadores de c?lulas tronco atrav?s da express?o imuno-histoqu?mica de Oct-4 e CD44 em uma s?rie de casos de les?es odontog?nicas epiteliais ben?gnas. A amostra foi constitu?da por 20 casos de ceratocisto odontog?nico (CCO), 20 caos de Ameloblastoma s?lido/multic?stico e 20 casos de Tumor Odontog?nico Adenomatoide (TOA). A express?o de Oct-4 e CD44 foi avaliada no epit?lio das les?es atrav?s do percentual de c?lulas positivas(PP) e da intensidade da express?o ( IE ), sendo realizado o somat?rio destes escores, resultando na Pontua??o de Imunomarca??o Total (PIT) que variou de 0 a 7. Os resultados do presente estudo foram analisados pelo valor da pontua??o de PIT. Todos os casos apresentaram positividade para os dois marcadores e a maioria exibiu alta express?o para ambos os marcadores. A an?lise da express?o de Oct-4 n?o revelou diferen?as estatisticamente significativas (p = 0,406) entre as les?es estudadas. Com rela??o ? express?o do CD44, houve diferen?a estatisticamente significativa entre os casos de ameloblastoma e CCO, apresentando este ?ltimo maior n?mero de casos no score 7 (p = 0,034). Na analise da correla??o da imunoexpress?o de ambos os marcadores nas tr?s les?es estudadas, n?o houve correla??o estatisticamente significativa . Os resultados do presente estudo identificaram a presen?a de c?lulas com caracter?sticas troncais dispostas em locais variados do componente epitelial das les?es ora estudadas sugerindo a sua poss?vel participa??o na histog?nese e diferencia??o em les?es odontog?nicas epiteliais benignas contribuindo assim para o desenvolvimento destas les?es. / benign epithelial odontogenic lesions are great clinical importance entities that develop in the jaws from the tissues that form teeth. It has been shown that in benign and malignant tumors, are present in a large number of tumor stem cells, which has great implications in the development of these lesions. Oct-4 and CD44 have been demos as important markers for tumoral stem cells. The objective of this study was to identify epithelial cells expressing stem cell markers by immunohistochemical expression of Oct-4 and CD44 in a series of cases of benign epithelial odontogenic lesions. The sample was comprised of 20 cases of odontogenic keratocyst (OKC), 20 cases of solid/multicystic ameloblastoma and 20 cases of adenomatoid odontogenic tumor (AOT). The expression of Oct-4 and CD44 was evaluated in epithelial lesions using the percentage of positive cells (PP) and the intensity of expression (IE), being realized the sum of these scores, resulting in Total Immunostaining Score (TIS) ranging 0 to 7. The results were submitted to the appropriate statistical test (nonparametric Kruskal-Wallis and Spearman correlation coefficient). All cases were positive for both markers and most showed high expression of both markers. The analysis of Oct-4 expression revealed no statistically significant differences (p = 0.406) among the studied lesions. Regarding the CD44 expression, there was a statistically significant difference between the cases of ameloblastoma and TOA in relation to the CCO, with the latter show more cases in the score 7 (p = 0.034). In the correlation analysis of the immunoreactivity of both markers in the three lesions studied, there was no statistically significant correlation. The results of this study identified the presence of cells with stemness characteristics arranged at various sites in the epithelial component of the studied lesions suggesting their possible role in the histogenesis and differentiation in benign epithelial odontogenic lesions, thus contributing to the development of these lesions.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-07-11T17:13:30Z No. of bitstreams: 1 LeorikPereiraDaSilva_DISSERT.pdf: 1755248 bytes, checksum: 7c7295f3b5a7cf31b5ae4aa23ab61afd (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-07-14T22:02:14Z (GMT) No. of bitstreams: 1 LeorikPereiraDaSilva_DISSERT.pdf: 1755248 bytes, checksum: 7c7295f3b5a7cf31b5ae4aa23ab61afd (MD5) / Made available in DSpace on 2016-07-14T22:02:14Z (GMT). No. of bitstreams: 1 LeorikPereiraDaSilva_DISSERT.pdf: 1755248 bytes, checksum: 7c7295f3b5a7cf31b5ae4aa23ab61afd (MD5) Previous issue date: 2016-02-19 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES) / Introdu??o: A endonuclease apur?nica/apurimid?nica (APE-1) ? uma prote?na essencial para a via do reparo por excis?o de bases (BER) do DNA, al?m de regula??o de atividades redox. A capacidade de c?lulas malignas em reconhecer e reparar danos no DNA ? um mecanismo importante para sobreviv?ncia tumoral, e estudos recentes sugerem que a superexpress?o da APE-1 pode se relacionar com o pobre progn?stico em alguns tumores. Objetivo: Analisar a imunoexpress?o da APE-1 em Adenomas Pleom?rficos (AP) e Carcinomas Ex-Adenomas Pleom?rficos (CaExAP) de gl?ndulas salivares. Materiais e M?todos: Foram selecionados 49 tumores fixados em formol e inclu?dos em parafina (33 AP e 16 CaExAP) que foram submetidos a estudo imuno-histoqu?mico pela t?cnica da imunoperoxidase. A imunoexpress?o da APE-1 foi avaliada de forma quantitativa pelo percentual de c?lulas imunopositivas. Para an?lise estat?stica foi adotado n?vel de signific?ncia de 5% (p ? 0,05). Resultados: Todos os casos de AP e CaExAP (n=49) foram positivos para APE-1, no entanto, houve maior express?o em CaExAP havendo diferen?a estatisticamente relevante (p<0,001). N?o foi encontrada associa??o da express?o da APE-1 entre tumores de gl?ndula salivar maior ou menor, entretanto, em AP n?o encapsulados (Mediana de express?o= 54,2%) houve maior express?o quando comparados a tumores encapsulados (p=0,02). A superexpress?o da APE-1 foi constatada principalmente em casos de CaExAP com met?stase linfonodal (Mediana de express?o= 90,3% - p=0,002) e padr?o invasivo (Mediana de express?o= 89,9% - p=0,003) quando comparados aos casos sem met?stase e intracapsulares. Conclus?o: Este estudo sugere que a APE-1 encontra-se desregulada nos tumores estudados. A maior express?o da APE-1 est? associada com a aus?ncia de c?psula completa em AP e a superexpress?o est? relacionada com o comportamento mais agressivo do CaExAP. / Introduction: Apurinic/Apyrimidinic Endonuclease 1 (APE-1) is an essential protein for DNA base excision repair (BER) pathway and regulation of redox activities. The ability of malignant cells to recognize and repair DNA damage is an important mechanism for tumor survival, and recent studies suggest that APE-1 overexpression is related to poor prognosis in some tumors. Purpose: To analyze the immunoreactivity of APE-1 in Pleomorphic Adenomas (PA) and Carcinomas Ex Pleomorphic Adenomas (CaExPA) of salivary glands. Materials and Methods: A total of 49 tumors fixed in formalin and embedded in paraffin (33 PA and 16 CaExPA) underwent immunohistochemical study by the immunoperoxidase technique. APE-1 immunoreactivity was evaluated quantitatively by the percentage of immunopositive cells. For statistical analysis a significance level of 5% (p? 0.05) was adopted. Results: All cases of PA and CaExPA (n=49) were positive for APE-1, however, there was a higher expression in CaExPA, with statistically significant difference (p<0.001). There was no association between APE-1 expression and tumors of major or minor salivary gland, however, not encapsulated PA (median expression = 54.2%) showed higher expression when compared to encapsulated tumors (p=0.02). APE-1 overexpression was found mainly in cases of CaExAP with lymph node metastasis (median expression = 90.3% - p=0.002) and invasive pattern (median expression = 89.9% - p=0.003), when compared to cases without metastasis and intracapsular pattern. Conclusion: This study suggests that APE-1 is deregulated in the studied tumors. The increased expression of APE-1 is associated with the absence of complete capsule in PA and it is associated with more aggressive behavior in CaExPA.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-07-11T17:13:30Z No. of bitstreams: 1 MaraLuanaBatistaSevero_DISSERT.pdf: 1279812 bytes, checksum: d55a74719b46a51718b7399d61a2a556 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-07-15T18:45:17Z (GMT) No. of bitstreams: 1 MaraLuanaBatistaSevero_DISSERT.pdf: 1279812 bytes, checksum: d55a74719b46a51718b7399d61a2a556 (MD5) / Made available in DSpace on 2016-07-15T18:45:17Z (GMT). No. of bitstreams: 1 MaraLuanaBatistaSevero_DISSERT.pdf: 1279812 bytes, checksum: d55a74719b46a51718b7399d61a2a556 (MD5) Previous issue date: 2016-02-25 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES) / Objetivo desse estudo foi analisar a imunoexpress?o de receptores de calcitonina (CTRs) e glicocorticoides (GCRs) em les?es centrais de c?lulas gigantes (LCCGs) agressivas e n?o agressivas. Trata-se de um estudo imuno-histoqu?mico (t?cnica da imunoperoxidase), quantitativo e descritivo de 52 casos de LCCGs dos ossos maxilares, nos quais 13 pacientes portadores de LCCG foram tratados com triancinolona intralesional ou calcitonina spray intranasal. A m?dia de imunomarca??o foi comparada entre os tipos celulares e subtipo cl?nico da les?o. O teste de Mann-Whitney foi realizado para essas compara??es. Dos 52 casos de LCCGs, 53.8% eram do g?nero feminino, com uma m?dia de idade de 25.69 anos. A mand?bula foi o s?tio anat?mico mais acometido. Trinta casos (57.7%) foram de LCCGs agressivas e 22 (42.3%) de n?o agressivas. A cirurgia foi o tratamento de escolha em 75% das LCCGs estudadas. Em 56.7% das LCCGs agressivas foi realizada cirurgia, enquanto 43.4% foram submetidas ao tratamento conservador. Dos submetidos ao tratamento conservador, a maioria (n = 8; 61.5%) respondeu bem ao tratamento. A express?o de CTR foi evidenciada em 67.3% da amostra e para o GCR em 96.15% dos casos. N?o houve diferen?a estatisticamente significante entre a express?o de CTRs e GCRs em c?lulas mononucleares e multinucleadas das LCCGs em rela??o ? agressividade, em rela??o ao tratamento realizado para os casos de les?es agressivas e em rela??o ? resposta ao tratamento conservador realizado nos casos de LCCGs agressivas (p>0.05). Os resultados da nossa pesquisa sugerem que a imunoexpress?o dos CTRs e GCRs n?o influenciou na resposta ao tratamento cl?nico com calcitonina ou triancinolona na amostra estudada e exibiu uma express?o variada independente da agressividade da les?o. / The aim of this study was to analyze the immunoexpression of calcitonin (CTR) and glucorticoid (GCR) receptors in aggressive and non-aggressive central giant cell lesions (CGCL). This is an immunohistochemistry study (immunoperoxidase technique) of 52 cases of CGCL of the jaws, in which 12 patients were treated with intralesional triamcinolone injections and one with calcitonin nasal spray. The mean of immunostaining was compared between the cell types and clinical subtype of the lesion. The correlations among means were analyzed by Mann-Whitney test. Of the 52 cases studied, 53.8% were females, with a mean of 25.69 years. Most lesions were located in the mandible. Thirty patients (57.7%) had aggressive lesions and 22 (42.3%) of the cases consisted of non-aggressive lesions. Surgery was the treatment of choice in 75% of the cases. In 56.7% of the aggressive CGCL surgery was performed, while 43.4% of patients were submitted to conservative treatment. Among cases submitted to conservative treatment, the majority (n = 8; 61.5%) responded well to treatment. CTR expression was observed in 67.3% and GCR in 96.15% of cases. There was no significant statistical difference between the expression of CTRs and GCRs in mononuclear and multinucleated CGCLscells, regarding aggressiveness, treatment performed for aggressive lesions and the response to conservative treatment (p>0.05). The results of our research suggest that the immunoreactivity of CTRs and GCRs did not influence the response to clinical treatment with calcitonin or triamcinolone in the sample studied and it exhibited a varied expression regardless of the aggressiveness of the lesion.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-07-25T23:14:34Z No. of bitstreams: 1 AngelicaLopesCordeiroMandu_DISSERT.pdf: 8297335 bytes, checksum: a571100e33585465a7dd9329c7047ab6 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-08-04T20:58:54Z (GMT) No. of bitstreams: 1 AngelicaLopesCordeiroMandu_DISSERT.pdf: 8297335 bytes, checksum: a571100e33585465a7dd9329c7047ab6 (MD5) / Made available in DSpace on 2016-08-04T20:58:54Z (GMT). No. of bitstreams: 1 AngelicaLopesCordeiroMandu_DISSERT.pdf: 8297335 bytes, checksum: a571100e33585465a7dd9329c7047ab6 (MD5) Previous issue date: 2016-02-18 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico (CNPq) / Os nevos melanoc?ticos (NMs) s?o prolifera??es benignas de c?lulas n?vicas, que podem serencontradas na pele e em mucosas de revestimento, incluindo a mucosa oral. Contudo, osNMs cut?neos s?o mais comuns, quando comparados os que acometem a mucosa oral. Osmecanismos moleculares envolvidos no desenvolvimento dos nevos e os fatores que podeminfluenciar no padr?o de migra??o das c?lulas n?vicas s?o pouco explorados. O objetivo destapesquisa foi analisar a express?o imuno-histoqu?mica das prote?nas E-caderina e Bcl-2 emNMs orais/cut?neos e relacion?-las com as caracter?sticas cl?nicas (sexo, idade, localiza??o,exposi??o ? radia??o solar) e tipos histopatol?gicos. Foram analisados 36 casos de NMs orais34 de NMs cut?neos. Foi utilizada a t?cnina de imuno-histoqu?mica das prote?nas E-caderinae bcl-2, na qual foram analisados a intensidade (fraca, intermedi?ria e forte) e distribui??o demarca??o (focal e difusa). A imunoexpress?o tamb?m foi analisada quanto aos tipos de c?lulasn?vicas (A, B e C). A an?lise estat?stica foi realizada atrav?s dos testes de Qui-Quadradode Pearson e Correla??o de Spearman com n?vel de signific?ncia estabelecido em 5%. Dos 70casos de NMs, 82,9% eram do sexo feminino, 48,6% com idade entre 26-50 anos, 60% eramda ra?a branca, 51,4% foram diagnosticados histopatologicamente como nevos intrad?rmicos/intramucosos e 80% eram NMs adquiridos. A express?o imuno-histoqu?mica da bcl2 e Ecaderinaforam vari?veis na amostra e n?o exibiram associa??o com os par?metros cl?nicos. Aexpress?o da bcl-2 e E-caderina foram vari?veis de acordo com os tipos de c?lulas n?vicas (A,B e C) (p=0,001). A express?o da bcl-2 foi mais difusa em NMs cong?nitos (p=0,002). A Ecaderinafoi positiva em 83,3% dos NMs <1cm (p=0,001) e em exibiu uma fraca marca??oem 73,9% dos NMs que se encontravam em ?reas expostas (p=0,010). Com base nestes resultados,sugere-se que a E-caderina tenha um controle na determina??o dos tipos histopatol?gicosdos NMs, e que a bcl-2 seja um poss?vel marcador de NMs com maior susceptibilidade aodesenvolvimento de les?es malignas. / Melanocytic nevi (MNs) are benign melanocytic proliferations of cells, which can be found in the skin and mucous coat, including the oral mucosa. However, skin NMs are more common when compared to those that affect the oral mucosa. The molecular mechanisms involved in the development of nevi and the factors that can influence the migration pattern of the nevus cells are little explored. The aim of this study was to analyze the immunohistochemical expression of E-cadherin protein and Bcl-2 in oral / skin NMs and relate them to the clinical characteristics (gender, age, location, exposure to solar radiation) and histopathological types. 36 cases of oral NMs and 34 Skin NMs were analyzed. The immunohistochemistry was used of the protein E-cadherin and bcl-2, which were analyzed the intensity (weak, moderate and strong) and distribution marking (diffuse and focal). The immunoreactivity also analyzed as to the types of nevus cells (epithelioid cells -A, -B lymphocyte and fibroblast-like -C). Statistical analysis was performed using the chi-square tests of Pearson and Spearman correlation with significance level set at 5%. Of the 70 cases of NMs, 82.9% were female, 48.6% aged 26-50 years, 51.4% were diagnosed histologically as intradermal / intramucosal nevi and 80% were NMs acquired. Immunohistochemical expression of BCL2 and E-cadherin were variables in the sample and showed no association with clinical parameters. The expression of bcl-2 and E-cadherin were variable according to the types of nevus cells (A, B and C) (P = 0.001). The expression of bcl-2 was more diffuse in congenital MNs (p = 0.002). E-cadherin was positive in 83.3% of MNs <1cm (p = 0.001) and exhibited weak staining in 73.9% of MNs that were in exposed areas (p = 0.010). Based on these results, it is suggested that the E-cadherin has a modulating effect on the migratory properties of NMs, and bcl-2 is a marker of MNs with increased proliferative capacity.